Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D018849:Controlled Clinical Trials as Topic; D003404:Creatinine / Q000097:blood*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology* / Q000517:prevention & control; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D011188:Potassium / Q000097:blood; D011379:Prognosis; D011945:Receptors, Angiotensin / Q000627:therapeutic use; D012084:Renin-Angiotensin System / Q000187:drug effects; D018570:Risk Assessment; D012720:Severity of Illness Index
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D011945:Receptors, Angiotensin; D003404:Creatinine; D011188:Potassium